1:08:05

A Patient Story

22:04

CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data – Dr O’ Brien, MD

19:00

CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data – Dr Ma, MD

15:59

CALQUENCE® (acalabrutinib) Long-Term Data – Dr Brem, MD

16:42

CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP

18:35

CALQUENCE® (acalabrutinib) ACE-CL-001 (ibrutinib-intolerant cohort) – Dr Raval, MD

15:22

CALQUENCE® (acalabrutinib) ELEVATE-TN data, incl. High-Risk Subgroups – Dr Abutalib, MD

14:09

CALQUENCE® (acalabrutinib) Safety Data – Dr Levy, MD